跳至主要内容
临床试验/ISRCTN98886991
ISRCTN98886991进行中(未招募)4 期

Pharyngeal Electrical stimulation for Acute Stroke dysphagia Trial (PhEAST)

niversity of Nottingham0 个研究点目标入组 800 人开始时间: 2021年10月5日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 14/11/2023:
  • 1. Hospitalised adults (age =18 years)
  • 2. Recent (4-31 days) ischaemic or haemorrhagic anterior or posterior circulation stroke (as diagnosed clinico-radiologically) at a comprehensive or primary care stroke centre
  • 3. Clinical dysphagia defined as a functional oral intake scale score of 1 (nothing by mouth, feeding by nasogastric tube [NGT]/percutaneous endoscopic gastrostomy [PEG] tube), 2 (tube dependent with minimal attempts of food or liquids) or 3 (tube dependent with consistent oral intake of food or liquids)
  • 4. NIHSS item 1a score of 0, 1 or 2 (where the patient requires repeated stimulation to arouse)
  • Previous inclusion criteria:
  • 1. Hospitalised adults (age =18 years)
  • 2. Recent (4-31 days) ischaemic or haemorrhagic anterior or posterior circulation stroke (as diagnosed clinico-radiologically) at a comprehensive or primary care stroke centre
  • 3. Clinical dysphagia defined as a functional oral intake scale score of 1 (nothing by mouth, feeding by nasogastric tube [NGT]/percutaneous endoscopic gastrostomy [PEG] tube) or 2 (tube dependent with minimal attempts of food or liquids)

排除标准

  • Current exclusion criteria as of 14/11/2023:
  • 1. Non-stroke dysphagia, e.g. due to traumatic brain haemorrhage, subarachnoid haemorrhage, brain tumour, Parkinson’s disease, multiple sclerosis, severe dementia, head or neck cancer
  • 2. Pre-stroke dysphagia or dependency (modified Rankin scale, mRS 4/5)
  • 3. NIHSS item 1a score of 2 (where the patient only responds to pain) or NIHSS item 1a score of 3
  • 4. Ongoing or anticipated ventilation/intubation/tracheostomy
  • 5. Ongoing treatment of dysphagia with other forms of electrical / magnetic stimulation e.g. NMES, TCDS, rTMS
  • 6. Malignant middle cerebral artery syndrome (although this typically presents before 4 days)
  • 7. Pacemaker, cochlear implant or implantable cardioverter-defibrillator
  • 8. Need for >35% of oxygen
  • 9. Patient expected to be repatriated to a separate organisation
  • 10. Patient expected to be rehabilitated at a separate organisation
  • 11. Patient not likely to be in the treating hospital for at least 14 days
  • 12. Two or more NGT tubes pulled out unless nasal bridle in place
  • 13. Investigator feels patient will not tolerate PES catheter
  • 14. Expected to be discharged or transferred to a site not running the trial during the PES treatment period
  • 15. Pregnancy if known at time of enrolment
  • 16. Participating in another randomised controlled treatment trial for post-stroke dysphagia
  • 17. Palliative care
  • Previous exclusion criteria:
  • 1. Non-stroke dysphagia, e.g., due to traumatic brain haemorrhage, subarachnoid haemorrhage, brain tumour, Parkinson’s disease, multiple sclerosis, severe dementia, head or neck cancer
  • 2. Pre-stroke dysphagia or dependency (modified Rankin scale [mRS] 4/5)
  • 3. Ongoing or anticipated ventilation/intubation/tracheostomy or use of electrical or magnetic stimulation
  • 4. Malignant middle cerebral artery syndrome
  • 5. Pregnant
  • 6. Pacemaker
  • 7. Need for >2 litres of oxygen
  • 8. Two or more NGT pulled out unless nasal bridle in place
  • 9. Investigator feels the patient will not tolerate PES catheter

研究者

发起方
niversity of Nottingham

相似试验